Compare $MPLT vs $RZLT | Chartloom

Compare

$MPLT vs $RZLT

MapLight Therapeutics Inc · Rezolute Inc

MPLT

MapLight Therapeutics Inc

RZLT

Rezolute Inc

Compare $MPLT vs $RZLT

Comparing MapLight Therapeutics Inc and Rezolute Inc

MPLTMapLight Therapeutics Inc

RZLTRezolute Inc

MPLTMapLight Therapeutics Inc

Market cap

$400M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-47.3%

52W performance

-51.9%

FCF yield

-43.7%

RZLTRezolute Inc

Market cap

$469M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

124.9%

52W performance

-44.2%

FCF yield

-13.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MPLT

RZLT

Detailed metrics comparison

MPLT

MapLight Therapeutics Inc

RZLT

Rezolute Inc

Market Cap

MPLT$400M

RZLT$469M

Enterprise Value

MPLT$329M

RZLT$458M

Price

MPLT$8.83

RZLT$4.87

P/E Ratio

MPLTN/A

RZLTN/A

P/S Ratio

MPLT0.00x

RZLT0.00x

EV/Sales

MPLT0.00x

RZLT0.00x

EV/EBITDA

MPLT0.00x

RZLT0.00x

P/B Ratio

MPLT1.57x

RZLT3.85x

P/FCF Ratio

MPLTN/A

RZLTN/A

EV/FCF

MPLT-1.88x

RZLT-7.09x

PEG Ratio

MPLTN/A

RZLTN/A

Forward P/E (NTM)

MPLTN/A

RZLTN/A

Forward P/S (NTM)

MPLTN/A

RZLTN/A

Revenue (TTM)

MPLT$0

RZLT$0

Revenue Growth (YoY)

MPLTN/A

RZLTN/A

Forward Rev Growth

MPLT949.5%

RZLT2194.8%

Gross Margin (TTM)

MPLT0.0%

RZLT0.0%

Operating Margin (TTM)

MPLT0.0%

RZLT0.0%

EBITDA Margin (TTM)

MPLT0.0%

RZLT0.0%

Net Margin (TTM)

MPLT0.0%

RZLT0.0%

FCF Margin (TTM)

MPLTN/A

RZLTN/A

Net Income (TTM)

MPLT$-230M

RZLT$-78M

FCF (TTM)

MPLT$-175M

RZLT$-65M

EPS (TTM)

MPLT-$5.06

RZLT-$0.74

ROE (TTM)

MPLT-6384.0%

RZLT-6299.0%

ROA (TTM)

MPLT-6033.0%

RZLT-5794.0%

ROIC (TTM)

MPLT-6384.0%

RZLT-6299.0%

Cash

MPLT$72M

RZLT$11M

Debt

MPLT$0

RZLT$0

Net Cash/Debt

MPLT$72M

RZLT$11M

Current Ratio (TTM)

MPLT16.52x

RZLT9.68x

Quick Ratio (TTM)

MPLT15.79x

RZLT9.44x

Debt/Equity (TTM)

MPLT0.00x

RZLT0.00x

Debt/Assets (TTM)

MPLT0.0%

RZLT0.0%

Interest Coverage (TTM)

MPLTN/A

RZLTN/A

Net Debt/EBITDA (TTM)

MPLT0.00x

RZLT0.00x

Beta

MPLT0.85

RZLT0.58

52W Performance

MPLT-51.9%

RZLT-44.2%

YTD Performance

MPLT-47.3%

RZLT124.9%

% from 52W High

MPLT-78.2%

RZLT-57.5%

% from 52W Low

MPLT1.5%

RZLT355.1%

Asset Turnover (TTM)

MPLT0.00x

RZLT0.00x

FCF Yield (TTM)

MPLT-43.7%

RZLT-13.8%

Earnings Yield (TTM)

MPLT-57.4%

RZLT-16.5%

Dividend Yield (TTM)

MPLTN/A

RZLTN/A

Rule of 40

MPLT0.0

RZLT0.0

EV/GP/RG

MPLTN/A

RZLTN/A

Ticker research

View MPLT research View RZLT research

Metric	MPLT MapLight Therapeutics Inc	RZLT Rezolute Inc
Market & Valuation
Market Cap	$400M	$469M
Enterprise Value	$329M	$458M
Price	$8.83	$4.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.57x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.88x	-7.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	949.5%	2194.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-230M	$-78M
FCF (TTM)	$-175M	$-65M
EPS (TTM)	-$5.06	-$0.74
ROE (TTM)	-6384.0%	-6299.0%
ROA (TTM)	-6033.0%	-5794.0%
ROIC (TTM)	-6384.0%	-6299.0%
Financial Health
Cash	$72M	$11M
Debt	$0	$0
Net Cash/Debt	$72M	$11M
Current Ratio (TTM)	16.52x	9.68x
Quick Ratio (TTM)	15.79x	9.44x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.85	0.58
52W Performance	-51.9%	-44.2%
YTD Performance	-47.3%	124.9%
% from 52W High	-78.2%	-57.5%
% from 52W Low	1.5%	355.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-43.7%	-13.8%
Earnings Yield (TTM)	-57.4%	-16.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MPLT research	View RZLT research

Valuation

P/S Ratio

MPLT

0.00x

RZLT

0.00x

EV/FCF

RZLT

-7.09x

MPLT

-1.88x

Growth & revenue

Forward Revenue Growth

RZLT

2194.8%

MPLT

949.5%

Profitability & performance

Gross Margin

MPLT

0.0%

RZLT

0.0%

ROE

RZLT

-6299.0%

MPLT

-6384.0%

FCF Yield %

RZLT

-13.8%

MPLT

-43.7%

52-Week Performance

RZLT

-44.2%

MPLT

-51.9%

Detailed metrics comparison

MPLT

MapLight Therapeutics Inc

RZLT

Rezolute Inc

Market Cap

MPLT$400M

RZLT$469M

Enterprise Value

MPLT$329M

RZLT$458M

Price

MPLT$8.83

RZLT$4.87

P/E Ratio

MPLTN/A

RZLTN/A

P/S Ratio

MPLT0.00x

RZLT0.00x

EV/Sales

MPLT0.00x

RZLT0.00x

EV/EBITDA

MPLT0.00x

RZLT0.00x

P/B Ratio

MPLT1.57x

RZLT3.85x

P/FCF Ratio

MPLTN/A

RZLTN/A

EV/FCF

MPLT-1.88x

RZLT-7.09x

PEG Ratio

MPLTN/A

RZLTN/A

Forward P/E (NTM)

MPLTN/A

RZLTN/A

Forward P/S (NTM)

MPLTN/A

RZLTN/A

Revenue (TTM)

MPLT$0

RZLT$0

Revenue Growth (YoY)

MPLTN/A

RZLTN/A

Forward Rev Growth

MPLT949.5%

RZLT2194.8%

Gross Margin (TTM)

MPLT0.0%

RZLT0.0%

Operating Margin (TTM)

MPLT0.0%

RZLT0.0%

EBITDA Margin (TTM)

MPLT0.0%

RZLT0.0%

Net Margin (TTM)

MPLT0.0%

RZLT0.0%

FCF Margin (TTM)

MPLTN/A

RZLTN/A

Net Income (TTM)

MPLT$-230M

RZLT$-78M

FCF (TTM)

MPLT$-175M

RZLT$-65M

EPS (TTM)

MPLT-$5.06

RZLT-$0.74

ROE (TTM)

MPLT-6384.0%

RZLT-6299.0%

ROA (TTM)

MPLT-6033.0%

RZLT-5794.0%

ROIC (TTM)

MPLT-6384.0%

RZLT-6299.0%

Cash

MPLT$72M

RZLT$11M

Debt

MPLT$0

RZLT$0

Net Cash/Debt

MPLT$72M

RZLT$11M

Current Ratio (TTM)

MPLT16.52x

RZLT9.68x

Quick Ratio (TTM)

MPLT15.79x

RZLT9.44x

Debt/Equity (TTM)

MPLT0.00x

RZLT0.00x

Debt/Assets (TTM)

MPLT0.0%

RZLT0.0%

Interest Coverage (TTM)

MPLTN/A

RZLTN/A

Net Debt/EBITDA (TTM)

MPLT0.00x

RZLT0.00x

Beta

MPLT0.85

RZLT0.58

52W Performance

MPLT-51.9%

RZLT-44.2%

YTD Performance

MPLT-47.3%

RZLT124.9%

% from 52W High

MPLT-78.2%

RZLT-57.5%

% from 52W Low

MPLT1.5%

RZLT355.1%

Asset Turnover (TTM)

MPLT0.00x

RZLT0.00x

FCF Yield (TTM)

MPLT-43.7%

RZLT-13.8%

Earnings Yield (TTM)

MPLT-57.4%

RZLT-16.5%

Dividend Yield (TTM)

MPLTN/A

RZLTN/A

Rule of 40

MPLT0.0

RZLT0.0

EV/GP/RG

MPLTN/A

RZLTN/A

Ticker research

View MPLT research View RZLT research

Metric	MPLT MapLight Therapeutics Inc	RZLT Rezolute Inc
Market & Valuation
Market Cap	$400M	$469M
Enterprise Value	$329M	$458M
Price	$8.83	$4.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.57x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.88x	-7.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	949.5%	2194.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-230M	$-78M
FCF (TTM)	$-175M	$-65M
EPS (TTM)	-$5.06	-$0.74
ROE (TTM)	-6384.0%	-6299.0%
ROA (TTM)	-6033.0%	-5794.0%
ROIC (TTM)	-6384.0%	-6299.0%
Financial Health
Cash	$72M	$11M
Debt	$0	$0
Net Cash/Debt	$72M	$11M
Current Ratio (TTM)	16.52x	9.68x
Quick Ratio (TTM)	15.79x	9.44x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.85	0.58
52W Performance	-51.9%	-44.2%
YTD Performance	-47.3%	124.9%
% from 52W High	-78.2%	-57.5%
% from 52W Low	1.5%	355.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-43.7%	-13.8%
Earnings Yield (TTM)	-57.4%	-16.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MPLT research	View RZLT research